Medicinal Bioconvergence Research Center Submits United States Patent Application for Method for Screening Anticancer Agent Inhibiting Binding of AIMP2-DX2 and HSP70

Press/Media: Press / Media

Period2019 Feb 1

Media coverage

1

Media coverage

  • TitleMedicinal Bioconvergence Research Center Submits United States Patent Application for Method for Screening Anticancer Agent Inhibiting Binding of AIMP2-DX2 and HSP70
    Media name/outletGLOPRM
    Country/TerritoryUnited States
    Date19/2/1
    PersonsSunghoon Kim